ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY >

2021 , Vol. 5 >Issue 3: 254 - 257

DOI: https://doi.org/10.37015/AUDT.2021.210018

Case Reports

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization

  • Savsani Esika ,
  • Tantawi, MD Mohamed ,
  • E. Wessner, MBA, RDMS, RVT Corinne ,
  • Lee, MD Philip ,
  • Lyshchik, MD, PhD Andrej ,
  • Anton, MD, PhD Kevin ,
  • M. Shaw, MD Colette ,
  • Liu, MD Ji-Bin ,
  • R. Eisenbrey, PhD John
Expand
  • aDepartment of Radiology, Thomas Jefferson University, Philadelphia, PA, USA

Received date: 2021-07-01

  Revised date: 2021-07-22

  Online published: 2021-08-31

Fold

Abstract

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing treatment response thereafter. We report a unique finding of a patient with multifocal HCC treated with transarterial radioembolization (TARE) with yttrium-90 (Y90) and transarterial chemoembolization (TACE). We compared contrast-enhanced ultrasound (CEUS) with contrast-enhanced magnetic resonance imaging (CE-MRI) in the evaluation of treatment response to demonstrate advantages of CEUS imaging technique and its early detection of viable tumor.

Key words： Contrast-enhanced ultrasound; Hepatocellular carcinoma; Transarterial radioembolization; Transarterial chemoembolization; Treatment response

Cite this article

Savsani Esika , Tantawi, MD Mohamed , E. Wessner, MBA, RDMS, RVT Corinne , Lee, MD Philip , Lyshchik, MD, PhD Andrej , Anton, MD, PhD Kevin , M. Shaw, MD Colette , Liu, MD Ji-Bin , R. Eisenbrey, PhD John . Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization[J]. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 2021 , 5(3) : 254 -257 . DOI: 10.37015/AUDT.2021.210018

References

[1] Cardarelli-Leite L, Hadjivassiliou A, Klass D, Chung J, Ho SGF, Lim HJ, et al. Current locoregional therapies and treatment strategies in hepatocellular carcinoma. Curr Oncol 2020; 27:s144-s151.
[2] Hibi T, Sugawara Y. Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint. Hepatobiliary Surg Nutr 2018; 7:134-135.
[3] Singh P, Anil G. Yttrium-90 radioembolization of liver tumors: what do the images tell us? Cancer Imaging 2014; 13:645-657.
[4] Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treat Rev 2019; 72:28-36.
[5] Kirchner T, Marquardt S, Werncke T, Kirstein MM, Brunkhorst T, Wacker F, et al. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Abdom Radiol (NY) 2019; 44:1554-1561.
[6] Piscaglia F, Ogasawara S. Patient selection for transarterial chemoembolization in hepatocellular carcinoma: importance of benefit/risk assessment. Liver Cancer 2018; 7:104-119.
[7] Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY) 2021.
[8] Eisenbrey JR, Forsberg F, Wessner CE, Delaney LJ, Bradigan K, Gummadi S, et al. US-triggered microbubble destruction for augmenting hepatocellular carcinoma response to transarterial radioembolization: a randomized pilot clinical trial. Radiology 2021; 298:450-457.
[9] Dietrich CF, Averkiou M, Nielsen MB, Barr RG, Burns PN, Calliada F, et al. How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open 2018; 4:E2-e15.
[10] Wink MH, Wijkstra H, De La Rosette JJ, Grimbergen CA. Ultrasound imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied Technol 2006; 15:93-100.
[11] Pang EHT, Chan A, Ho SG, Harris AC. Contrast-enhanced ultrasound of the liver: optimizing technique and clinical applications. AJR Am J Roentgenol 2018; 210:320-332.
[12] Xu E, Long Y, Li K, Zeng Q, Tan L, Luo L, et al. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperthermia 2019; 35:159-167.
[13] Kudo M. Breakthrough imaging in hepatocellular carcinoma. Liver Cancer 2016; 5:47-54.
Options
Outlines

/

〈 〉

Content
For Authors
For Reviewers
Article Category
Publisher Policies
About
Top 10 Rankings

Share: WeChat

Copyright ©2018 Advanced Ultrasound in Diagnosis and Therapy

|

Creative Commons License Advanced Ultrasound in Diagnosis and Therapy (AUDT)  is licensed under a Creative Commons Attribution 4.0 International License.